AZN•benzinga•May 19, 2025 at 04:19 PM

AstraZeneca Announces Statistically Significant And Clinically Meaningful BATURA Phase III Trial Results Provide New Evidence For Airsupra As Standard Of Care For As-Needed Rescue Treatment In Asthma; Says Airsupra Demonstrated A 47% Reduction In The Risk

No summary available.

Read the full article from the original source for complete details and context.

Article published on May 19, 2025 by benzinga